Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingWages, Salaries and Other
Ratios

Capricor Therapeutics (CAPR) Shares Outstanding: 2011-2025

Historic Shares Outstanding for Capricor Therapeutics (CAPR) over the last 15 years, with Sep 2025 value amounting to $45.7 million.

  • Capricor Therapeutics' Shares Outstanding rose 13.35% to $45.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.7 million, marking a year-over-year increase of 13.35%. This contributed to the annual value of $45.6 million for FY2024, which is 46.34% up from last year.
  • Capricor Therapeutics' Shares Outstanding amounted to $45.7 million in Q3 2025, which was up 0.01% from $45.7 million recorded in Q2 2025.
  • In the past 5 years, Capricor Therapeutics' Shares Outstanding ranged from a high of $45.7 million in Q3 2025 and a low of $22.8 million during Q1 2021.
  • For the 3-year period, Capricor Therapeutics' Shares Outstanding averaged around $35.9 million, with its median value being $32.0 million (2024).
  • Data for Capricor Therapeutics' Shares Outstanding shows a peak YoY soared of 148.11% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Capricor Therapeutics' Shares Outstanding stood at $24.2 million in 2021, then rose by 4.37% to $25.2 million in 2022, then rose by 23.40% to $31.1 million in 2023, then spiked by 46.34% to $45.6 million in 2024, then climbed by 13.35% to $45.7 million in 2025.
  • Its Shares Outstanding stands at $45.7 million for Q3 2025, versus $45.7 million for Q2 2025 and $45.7 million for Q1 2025.